-
Entrée de catalogue: Adverse Reaction Reporting and Health Product Safety Information - Guide for...
MedEffect™ Canada provides a simple and efficient means for health professionals to report an adverse reaction to the Canada Vigilance Program. It also serves as a centralized...-
Fichier disponible au téléchargement dans les formats suivants :
- HTML
-
Entrée de catalogue: A Patient Guide for Reporting Side Effects from Health Products
2011 Health Canada brochure-
Fichier disponible au téléchargement dans les formats suivants :
- HTML
-
Entrée de catalogue: Summary Safety Review - ESSURE Permanent Birth Control System - Assessing...
Health Canada carried out a safety review due to concerns regarding complications associated with the Essure device after it is inserted into the fallopian tubes. In certain...-
Fichier disponible au téléchargement dans les formats suivants :
- HTML
-
Entrée de catalogue: Summary Safety Review - Celecoxib - Assessing the Risk of Serious Heart and...
Health Canada carried out a safety review of all the available evidence to evaluate the risk of side effects related to heart and stroke linked with celecoxib, in comparison to...-
Fichier disponible au téléchargement dans les formats suivants :
- HTML
-
Entrée de catalogue: Summary Safety Review - Antidepressants - Assessing the Potential Risk of...
Health Canada carried out this safety review when it became aware that the FDA was investigating the risk of angle-closure glaucoma linked to antidepressant use. Angle-closure...-
Fichier disponible au téléchargement dans les formats suivants :
- HTML
-
Entrée de catalogue: Summary Safety Review - Alpha Lipoic Acid - Assessing the Potential Risk of...
This safety review was carried out by Health Canada after the publication of case reports of IAS (insulin autoimmune syndrome) causing hypoglycemic episodes linked with the use...-
Fichier disponible au téléchargement dans les formats suivants :
- HTML
-
Entrée de catalogue: Summary Safety Review - Gabapentin - Assessing the Potential Risk of Serious...
In 2014, the product information for gabapentin products was updated to warn about the risk of serious breathing problems (respiratory depression) when it is used with an...-
Fichier disponible au téléchargement dans les formats suivants :
- HTML
-
Entrée de catalogue: Summary Safety Review - GARDASIL (Quadrivalent Human Papillomavirus [Types...
The safety of all vaccines, including Gardasil, is under continuous monitoring by Health Canada and the Public Health Agency of Canada. The safety of Gardasil was reassessed as...-
Fichier disponible au téléchargement dans les formats suivants :
- HTML
-
Entrée de catalogue: Summary Safety Review - Hydrocodone-containing products - Assessing the Risk...
It is known that hydrocodone can slow breathing when too much is taken. The labelling for these drugs already warns of this risk and it applies to all ages, including children....-
Fichier disponible au téléchargement dans les formats suivants :
- HTML
-
Entrée de catalogue: Summary Safety Review - INTUNIV XR (guanfacine hydrochloride) - Assessing...
A safety review was carried out to evaluate the potential risk of Raynaud's phenomenon in patients taking Intuniv XR. Raynaud's phenomenon is a disorder of the blood vessels,...-
Fichier disponible au téléchargement dans les formats suivants :
- HTML
-
Entrée de catalogue: Summary Safety Review - KEPPRA (levetiracetam) - Assessing the Potential...
Health Canada reviewed the potential risk of acute kidney injury with the use of levetiracetam, because of an article that was published by the WHO suggesting this risk. Health...-
Fichier disponible au téléchargement dans les formats suivants :
- HTML
-
Entrée de catalogue: Summary Safety Review - Lanoxin, Toloxin, Apo-digoxin, PMS-digoxin,...
Health Canada completed a safety review to evaluate if using digoxin was linked to a higher risk of death compared to patients not using digoxin. Results of the studies...-
Fichier disponible au téléchargement dans les formats suivants :
- HTML
-
Entrée de catalogue: Summary Safety Review - Levetiracetam and Methotrexate - Assessing the...
Health Canada carried out a safety review after learning that the European Medicines Agency was looking into a potential interaction between levetiracetam and methotrexate. The...-
Fichier disponible au téléchargement dans les formats suivants :
- HTML
-
Entrée de catalogue: Summary Safety Review - Loratadine - Abnormal heart rhythm (QT interval prolongation)
Health Canada carried out a safety review to investigate the potential risk of developing an abnormal heart rhythm (QT interval prolongation) with the use of over-the-counter...-
Fichier disponible au téléchargement dans les formats suivants :
- HTML
-
Entrée de catalogue: Summary Safety Review - Oral Retinoid Products - Assessing the Potential...
Health Canada reviewed the potential risk of impotence (erectile dysfunction) with the use of oral retinoids because of a publication from the Netherlands that linked...-
Fichier disponible au téléchargement dans les formats suivants :
- HTML
-
Entrée de catalogue: Summary Safety Review - Over-the-counter topical acne products containing...
A safety review was carried out to evaluate a potential link between serious allergic reactions (hypersensitivity reactions) and over-the-counter acne products containing either...-
Fichier disponible au téléchargement dans les formats suivants :
- HTML
-
Entrée de catalogue: Summary Safety Review - Phenylephrine and acetaminophen - Drug-drug interaction
Health Canada initiated a safety review following a report by the European Medicines Agency about the potential drug-drug interaction between phenylephrine and acetaminophen....-
Fichier disponible au téléchargement dans les formats suivants :
- HTML
-
Entrée de catalogue: Summary Safety Review - ZOFRAN (ondansetron) - Assessing the Potential Harm...
Health Canada carried out a safety review to assess the risk of birth defects with the use of ondansetron, as part of routine health product monitoring and because this drug is...-
Fichier disponible au téléchargement dans les formats suivants :
- HTML
-
Entrée de catalogue: Summary Safety Review - Viscous Lidocaine 2% - Assessing the Potential Risk...
Health Canada carried out a safety review to assess the potential risk of severe side effects in infants and young children with the use of viscous lidocaine. The issue was...-
Fichier disponible au téléchargement dans les formats suivants :
- HTML
-
Entrée de catalogue: Summary Safety Review - ULORIC (febuxostat) - Assessing a Possible Risk of...
Health Canada carried out a safety review after finding international cases of DRESS suspected of being linked with the use of Uloric (febuxostat). DRESS describes a group of...-
Fichier disponible au téléchargement dans les formats suivants :
- HTML
Vous pouvez également accéder à ce catalogue en utilisant l'API (cf. Documentation de l'API).